LifeScience Cell & Gene
Unixell Biotech Secures US FDA IND Clearance For iPSC Derived Epilepsy Cell Therapy
Unixell Biotech achieved a significant milestone as UX-GIP001, its iPSC-derived allogeneic cell therapy targeting focal epilepsy, secured Investigational N...
March 16, 2026 | News
Locus Cell And Charles River Sign Strategic MoU To Advance Cell And Gene Therapy Manufacturing In APAC
Locus Cell Co., Ltd. ("Locus Cell"), a Taiwan-based cell and gene therapy (CGT) Contract Development and Manufacturing Organization (CDMO), and Charles Riv...
March 13, 2026 | News
Merck And Cyto Facto Partner To Advance Lentiviral Manufacturing For Cell And Gene Therapies In APAC
Collaboration aims to support development of a robust lentiviral production platform for gene therapy applications Merck’s VirusExpress™293T...
March 12, 2026 | News
Tsingke Biotech And iGeneTech Form Strategic Alliance To Accelerate Synthetic Biology Innovation
Beijing Tsingke Biotech Co., Ltd. ("Tsingke Biotech") and iGeneTech Bioscience Co., Ltd. ("iGeneTech") have announced a strategic partnership aimed at adva...
March 11, 2026 | News
BrainXell Launches Human iPSC Derived Sensory Neurons Platform To Advance Pain And Ion Channel Research
BrainXell announced the launch of its human induced pluripotent stem cell (iPSC)-derived sensory neurons, a scalable human cellular platform engineer...
March 06, 2026 | News
Terumo BCT Launches C> Ecosystem Blueprint To Enable Scalable Cell And Gene Therapy Development In APAC
A collaborative integration model to enable practical, scalable cell and gene therapy delivery. Terumo Blood and Cell Technologies (Terumo BCT) annou...
March 06, 2026 | News
Antengene Grants UCB Global Rights To Develop And Commercialise ATG 201 Bispecific T Cell Engager
Antengene grants UCB worldwide exclusive rights to develop, manufacture and commercialize ATG-201, a CD19/CD3 bispecific T-cell engager (TCE) antibody, t...
March 05, 2026 | News
ISCT And JSRM Form Five Year Global Partnership To Accelerate Clinical iPSC Therapies
The International Society for Cell & Gene Therapy (ISCT), the translation-focused global community of cell and gene therapy experts and the Japanese So...
March 05, 2026 | News
XellSmart Secures Fourth Dual US And China Regulatory Clearance For iPSC Derived Cell Therapy In Multiple System Atrophy
XellSmart Pharmaceutical Co., Ltd. (XellSmart) announced that it had secured its fourth US FDA and China NMPA clearance for P...
March 04, 2026 | News
PHCbi Launches LiCellGrow Cell Expansion System To Advance CGT Manufacturing Efficiency
PHC Corporation’s Biomedical Division (Head Office: Chiyoda-ku, Tokyo; President: Nobuaki Nakamura; hereinafter “PHCbi”), a global provid...
March 03, 2026 | News
Takeda And Protagonist Secure FDA Priority Review For Rusfertide In Polycythemia Vera
Rusfertide Demonstrated Significant Improvements in Hematocrit Control, Phlebotomy Reduction and Patient Reported Outcomes for Patients with Polycythem...
March 03, 2026 | News
Japan Launches Elevidys Gene Therapy For Young Children With Duchenne Muscular Dystrophy
- Japan now offers ELEVIDYS gene therapy to children with Duchenne muscular dystrophy aged 3 years to less than 8 years - Company is eligible ...
February 27, 2026 | News
Astellas And Vir Biotechnology Forge Global Partnership To Advance VIR 5500 In Prostate Cancer
- Astellas and Vir Biotechnology to co-develop and co-commercialize VIR-5500 through a sharing of expenses and revenues - - Astellas to lead commerci...
February 25, 2026 | News
iRegene Advances Global Cell Therapy Programme With Key Parkinson’s And MSA Clinical Milestones
The global race to treat neurodegenerative diseases has reached a new tempo as iRegene Therapeutics pushes its cell therapy pipeline into key clinical...
February 25, 2026 | News
Most Read
- How Does GLP-1 Work?
- Innovations In Magnetic Resonance Imaging Introduced By United Imaging
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
